(Q42980879)

English

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks

scientific article published on 14 August 2008

Statements

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks (English)
Maribel Rodriguez-Torres
Moises Diago
Thomas Morgan
Bhupinderjit Anand
Karl Barange
Frank Suter
Gregory Hooper
Mitchell Shiffman
14 August 2008
237-241

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit